Grifols, S.A. (GRFS) Social Stream
GRIFOLS SA (GRFS) Price Targets From Analysts
Use the tables below to see what analysts covering GRIFOLS SA think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 29 months, GRFS's average price target has gone down $18.43.
GRFS reports an average of 20.37% for its upside potential over the past 36 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
GRFS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
GRFS's average broker recommendation rating worsened by 0.67 over the prior 13 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how GRIFOLS SA fares relative to all US stocks, note that its variance in analysts' estimates is lower than 92.56% of that group.
- In the context of stocks in the large market cap category, GRIFOLS SA's number of analysts covering the stock is greater than 16.27% of them.
- GRFS has a greater average analyst price target than 45.62% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, GRIFOLS SA's upside potential (average analyst target price relative to current price) is higher than 219.37% of them.
Is GRFS a Buy, Hold or Sell? See the POWR Ratings now!